Alkaloid AD Skopje

Alkaloid AD Skopje

ALK
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Alkaloid's mission is to improve health and quality of life by providing high-quality, accessible pharmaceutical and consumer healthcare products. The company has achieved a dominant market position in Southeast Europe, established a resilient export business, and built a reputation for reliability over nearly nine decades. Its strategy is centered on leveraging its integrated operations, portfolio diversification, and regional distribution strength to drive sustainable growth in both domestic and international generic drug and consumer health markets.

CardiovascularCentral Nervous SystemGastrointestinalAnti-infectiveConsumer Health

Technology Platform

Vertically integrated generic drug development and manufacturing platform, with core expertise in pharmaceutical formulation, bioequivalence studies, and GMP-compliant production of a wide range of dosage forms.

Opportunities

The growing demand for cost-effective generics in Southeast Europe's cost-contained healthcare systems provides a stable core opportunity.
Expansion into adjacent semi-regulated export markets and the development of higher-margin OTC and dermocosmetic brands offer avenues for diversified growth.

Risk Factors

Significant exposure to government-mandated drug price reductions across Europe threatens core generic margins.
Revenue concentration in the domestic Macedonian market and a few key export countries creates geographic vulnerability to regional economic or political instability.

Competitive Landscape

Faces intense competition from large global generic conglomerates (e.g., Teva, Sandoz) on price and portfolio breadth, and from other regional generic manufacturers in the Balkans. Its competitive edge lies in vertical integration, deep local market knowledge, and strong brand loyalty in its core regions.